Aptose Biosciences (APTO) PT Lowered to $5 at RBC Capital
Tweet
Share
E-mailGet Alerts APTO Hot Sheet
Price: $1.71 --0%
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 1 | Down: 1 | New: 0
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 1 | Down: 1 | New: 0
Join SI Premium – FREE
RBC Capital analyst Gregory Renza lowered the price target on Aptose Biosciences (NASDAQ: APTO) to $5.00 (from $6.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Kepler Cheuvreux Resumes Gerresheimer AG (GXI:GR) (GRRMF) at Reduce
- Ajinomoto (2802:JP) (AJINY) PT Raised to JPY6,900 at Citi
- Citi Upgrades Ming Yuan Cloud Group Holdings Ltd (909:HK) to Buy
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
